AUA CAPITAL MANAGEMENT, LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 213 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
AUA CAPITAL MANAGEMENT, LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$785
-21.5%
28
-31.7%
0.00%0.0%
Q3 2022$1,0000.0%410.0%0.00%0.0%
Q2 2022$1,0000.0%41
+36.7%
0.00%0.0%
Q1 2022$1,0000.0%300.0%0.00%0.0%
Q4 2021$1,00030
+30.4%
0.00%
Q3 2021$0
-100.0%
23
-25.8%
0.00%
-100.0%
Q2 2021$1,0000.0%310.0%0.00%0.0%
Q1 2021$1,0000.0%31
-24.4%
0.00%0.0%
Q4 2020$1,0000.0%41
-35.9%
0.00%0.0%
Q3 2020$1,000640.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
MQS Management LLC 10,935$255,0000.41%
GLOBEFLEX CAPITAL L P 144,692$3,370,0000.34%
CORNERCAP INVESTMENT COUNSEL INC 58,975$1,374,0000.20%
Factorial Partners, LLC 10,900$254,0000.17%
FEDERATED HERMES, INC. 3,464,335$80,684,0000.15%
Campbell & CO Investment Adviser LLC 14,800$345,0000.12%
FULLER & THALER ASSET MANAGEMENT, INC. 611,462$14,241,0000.08%
Summit Global Investments 45,900$1,069,0000.07%
RENAISSANCE GROUP LLC 63,559$1,480,0000.06%
PDT Partners, LLC 33,459$779,0000.06%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders